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of acute generalized exanthematous
pustulosis (AGEP) and its
differentiation from generalized
pustular psoriasis
Background: Acute generalized exanthematous pustulosis (AGEP)
represents a severe, acute, pustular skin reaction that is most often
induced by drugs. AGEP can be difﬁcult to differentiate from
generalized pustular psoriasis (GPP) both clinically and
histopathologically. We present a systematic description of the
histopathological spectrum of AGEP and GPP with a focus on
discriminating features.
Materials and methods: A retrospective, descriptive, comparative
histopathological study was completed utilizing step sections of
43 biopsies of 29 cases with a validated diagnosis of probable or deﬁnite
AGEP and 24 biopsies of 19 cases with an established diagnosis of GPP.
Results: In AGEP, biopsies from erythema and pustules showed
minor differences, whereas histopathology of the acute stage of GPP
showed major differences compared to the chronic stage. Comparing
AGEP and GPP, the presence of eosinophils, necrotic keratinocytes, a
mixed interstitial and mid-dermal perivascular inﬁltrate and absence of
tortuous or dilated blood vessels were in favor of AGEP. Moreover,
chronic GPP was characterized by prominent epidermal psoriatic
changes. The frequency of a psoriatic background of AGEP patients in
our study was higher than that of psoriasis in the general population.
However, histopathology of a subgroup of AGEP patients with a
personal history of psoriasis revealed no signiﬁcant differences from the
other AGEP patients.
Conclusions: The spectrum of histopathological features of both
AGEP and GPP is presented. Despite considerable overlap, subtle
consistent histopathological differences and the grade of severity of
speciﬁc features can help in differentiation. We could neither
substantiate earlier reports that follicular pustules exclude AGEP nor
did we see vasculitis as a speciﬁc feature in AGEP. Our study also
supports the concept that AGEP is a separate entity that is distinct
from GPP.
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1220Histopathology of AGEP–GPP
In the past, most widespread sterile pustular erup-
tions were classiﬁed as generalized pustular psoriasis
(GPP), a rare variant of psoriasis with several sub-
types. The most severe and recalcitrant variant, the
von Zumbusch type, is characterized by an acute
generalized eruption of pustules on an erythematous
base, sometimes lasting for weeks and often accom-
panied by fever and leukocytosis. Other types, such
as annular pustular psoriasis, are subacute or even
chronic and can either be widespread or localized.
Psoriasis vulgaris may proceed, accompany or follow
the pustular episode.1–3
In 1968, in acomprehensive reviewof 104 casesof
GPP,Baker and Ryan1 identiﬁed on clinicalgrounds
ﬁve cases of exanthematous pustular psoriasis with
short self-limiting courses which were presumably
precipitated by infections and/or drugs. In 1980,
Beylot et al.4 termed this rare reaction type as
acute generalized exanthematous pustulosis (AGEP).
AGEP is mainly induced by drugs, but occasionally
it can be precipitated by other causes such as viral
infections.5 Pustular rashes similar to AGEP have
been described as toxic pustuloderma, pustular drug
rash, (subcorneal) pustular drug eruption or drug-
induced GPP.6–10
Clinically, AGEP is characterized by the sudden
appearance of dozens of sterile, non-follicular, small
pustules on edematous erythema with a widespread
distribution or a predilection for the face and/or
skin folds. Mild non-erosive mucosal involvement,
mostly oral, may sometimes occur. Other skin signs
such as facial edema, purpura, target-like lesions and
blisters have been described but are not typical for
AGEP. Fever, neutrophilia and peripheral blood
eosinophilia (in a third of patients) are present.
After elimination of the causative culprit, pustules
associated with AGEP disappear in a few days,
typically followed by postpustular desquamation,
and the reaction fully resolves within 15 days.
Usually, internal organs are not involved and overall
prognosis is good, although lethal outcome has been
reported.11,12
AGEP can be difﬁcult to differentiate from GPP
both clinically and histopathologically. Clinically,
signs in favor of AGEP are abrupt onset, short
duration, polymorphous lesions, association with
recently started drugs and spontaneous healing after
their elimination, non-recurrence and absence of
arthritis or a personal or family history of psoriasis.
Knowledge of the histopathology of both AGEP and
GPP is based on case reports and small clinical
studies.4,13–22 Histopathological differentiation of
AGEP from GPP has not been well documented
and some even consider distinction based strictly
on dermatopathology to be impossible.23 The
aim of the present study was to characterize the
histopathological spectrum of AGEP and GPP and
to ﬁnd clues for differentiating these two disorders.
Materials and methods
Materials
We included 29 consecutive cases, evaluated as
deﬁnite or probable AGEP,and 19 consecutive cases
of GPP, that visited the Department of Dermatology
oftheUniversityMedicalCenterGroningenbetween
1992 up until mid-2009 and for which biopsies of the
active phase were available. All patients were seen in
the active phase of the disease. Clinical information,
charts, photographs, slides and information on the
typeanddurationofthelesionfromwhichthebiopsy
was taken were available. Diagnosis and grade of
probability of AGEP (23 deﬁnite and 6 probable)
were evaluated according to the validation system
of Sidoroff et al.11 Diagnosis of GPP was based on
history, course, clinical charts and photographs.1–3
Biopsies were divided into subgroups: those for
AGEP taken from erythema or a visible pustule,
and those for GPP taken from acute pustules on
erythematous, recently uninvolved skin representing
acute GPP (aGPP), or from pustules on longer
existing lesions, representing chronic GPP (cGPP).
In each subgroup, only one biopsy of a case was
randomly selected.
From the enrolled cases of AGEP, 43 biopsies (27
from visible pustules and 16 from erythema) and
from GPP, 24 biopsies (14 from aGPP and 10 from
cGPP) were studied.
Pathologic evaluation
The study was performed on step sections (regularly
including additional step sections) of parafﬁn-
embedded tissue, stained with hematoxylin and
eosin. All processed slides were systematically
evaluated according to parameters and grades listed
in Table 1. Scoring was based on independent
investigation by the ﬁrst two authors, followed by
a mutual meeting at a two-headed microscope where
consensus was reached. The ﬁrst author was the
treating physician, not blinded for diagnosis, while
the second author had no other information than the
pending differential diagnosis.
Statistical analysis
We used the Fisher exact test for comparison of
groups with respect to dichotomous variables. For
comparison of groups with respect to severity scores,
a linear trend test with exact calculated p values
was used. A two-sided p value of 0.05 or less was
considered as statistically signiﬁcant. Data were
analyzedusingSPSS(version16,SPSS,Chicago, IL).
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Table 1. Scoring system of histopathological parameters used for evaluation of acute generalized exanthematous pustulosis and generalized
pustular psoriasis
Parameter/severity score 0 1 2 3
Pustule size∗ No <10 Keratinocytes 10–15 Keratinocytes 16–30 Keratinocytes
Macro-pustule size No 31–60 Keratinocytes >60 Keratinocytes —
Spongiform character pustule No Mild Moderate Severe
Munro(-like) abscesses No 1 2 >2
Hair follicular pustule No Accessory† Predominant Solitary‡
Necrotic keratinocytes No 1 or 2 3–10 >10
Neutrophilic exocytosis No Few Scattered Many
Spongiosis No Mild Moderate Vesicles
Papillary edema No Mild Moderate Severe
Inﬁltrates No Mild Moderate Dense
Eosinophils (pustule) No 1 or 2 3–5 >5
Eosinophils (dermal) No 1 or 2 3–10 >10
Neutrophils (dermal, papillary) No Few Scattered Full ﬁelds
Leukocytoclasia No Mild Moderate Severe
Vasculitis No 1 Vessel 2 Vessels >2 Vessels
Hyperkeratosis No Mild Moderate Severe
Parakeratosis No Mild Moderate Severe
Granular cell layer Totally preserved Mostly preserved Severely diminished Missing
Rete ridge changes (elongation,
fusion and/or clubbing)
No Mild Moderate Severe
Mitosis No <1.5/HPF 1.5–2.4/HPF ≥2.5/HPF
Suprapapillary plate thinning No 1 Papilla 2 Papillae >2 Papillae
Tortuous, dilated blood vessels No 1 Capillary loop 2 Capillary loops >2 Capillary loops
HPF, high power ﬁeld at magniﬁcation 40× (0.25 mm2).
∗Pustule size: in case of several pustules, the largest is documented.
†Only in conjunction with other types of pustules (hair follicular pustule, accessory).
‡Without other types of pustules (hair follicular pustule, solitary).
Results
The gender–age distribution in AGEP was 12 male,
17 female, mean age 58.2 years (range 3–86), and in
GPP 5 male, 14 female, mean age 55.6 years (range
0–80).
The detailed spectrum of the histopathological
features in our study of 43 biopsies (27 from pus-
tules and 16 from erythema) of AGEP is presented
in Table 2. All biopsies showed at least one pustule.
We observed intracorneal and subcorneal pustules,
sometimes contiguous to intraepidermal or intra-
corneal, and combinations of these pustules in
various sizes (Fig. 1A,E). Although often present at
several levels, the accent of the pustules was gen-
erally subcorneal to subcorneal/intraepidermal. All
pustules were neutrophil-rich with acantholytic epi-
dermal cells and 58% also contained eosinophils
(generally sparse). Most spongiform were the sub-
corneal/intraepidermal pustules (Fig. 1C). Although
pustules were generally non-follicular, follicular pus-
tules were observed as well (26%), most often
accessory to other pustules, but incidentally also soli-
tary. Munro(-like) abscesses (Fig. 1E) were noticed
in 21% and macro-pustules in 40% of the biopsies
(Fig. 1A,B,D).
Solitary necrotic keratinocytes (88%), most often
discrete, neutrophilic exocytosis (91%) and spon-
giosis (100%) were common (Fig. 1C,E). Papillary
edema (91%) was mostly discrete (Fig. 1A,C,D).
Superﬁcial and mid-dermal perivascular inﬁltrates,
as well as interstitial inﬁltrates, were always present
and of a mixed cellular type, generally also con-
taining neutrophils (100%) and eosinophils (95%)
(Fig. 1A–E). Often, mid-dermal inﬁltrates were also
localized rather deep, lower than the upper third of
the mid-dermis. The majority of cases showed ery-
throcyte extravasation and leukocytoclasia (Fig. 1E),
but vasculitis, expressed by ﬁbrinoid changes of the
endothelial wall, was seen in only one patient.
Parakeratosis and rete ridge changes such as elon-
gation, clubbing and fusion were regularly present,
but often ratherdiscrete. Other psoriasiform features
such as hyperkeratosis, suprapapillary plate thinning
and tortuous, dilated blood vessels were absent or
onlyseeninaminority(Fig. 1D).Themitoticratewas
generally under 1.5/high power ﬁeld of 0.25 mm2.
Histopathologically biopsies taken from ery-
thema all revealed small pustules, mainly subcorneal
to subcorneal/intraepidermal, whereas those from





Fig. 1. Histopathology of acute generalized exanthematous pustulosis. A) Spongiform pustules at various epidermal levels. B) Slightly
spongiform subcorneal macro-pustule with a superﬁcial and (lower) mid-dermal, perivascular and interstitial dermal inﬁltrate. C) Slightly
spongiform subcorneal-intraepidermal pustule, minor acanthotic rete ridge changes, spongiosis, neutrophilic exocytosis, papillary edema and
a mixed perivascular and interstitial inﬁltrate. D) Subcorneal macro-pustule, slightly acanthotic rete ridge changes, papillary edema, dilated
papillaryvessels,mixedperivascularandinterstitialinﬁltrates.E) Smallsub-/intracornealpustulecontiguouswithaMunro-likeabscess(arrow),
spongiosis, few epidermal necrotic keratinocytes (arrowheads), erythrocyte extravasation, discrete leukocytoclasia and mixed perivascular and
interstitial inﬁltrate including eosinophils. Hematoxylin and eosin, original magniﬁcation: (A) ×50, (B) ×40, (C) ×100 and (D,E) ×200.
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Table 2. Prevalence of histopathological features in pustules and erythema in AGEP
Prevalence
AGEP total n = 43 AGEP pustule n = 27 AGEP erythema n = 16
Histopathological parameters (grade 2,3) (grade 2,3) (grade 2,3)
Pustules
Munro(-like) abscesses 9 (5) 7 (4) 2 (1)
Intra-/subcorneal pustules 39 (24) 24 (18) 15 (6)
Spongiform 31 (16) 18 (12) 13 (4)
Subcorneal-intraepidermal pustules 26 (24) 18 (18) 8 (6)
Spongiform 26 (18) 18 (15) 8 (3)
Eosinophils in pustule 25 (10) 16 (9) 9 (1)
Macro-pustules 17 (12) 17 (12) 0 (0)
Hair follicular pustules 11 8 3
Epidermis
Necrotic keratinocytes 38 (23) 22 (16) 16 (7)
Neutrophilic exocytosis 39 (20) 26 (16) 13 (4)
Spongiosis 43 (19) 27 (12) 16 (7)
Dermis
Papillary edema 39 (17) 25 (12) 14 (5)
Superﬁcial inﬁltrate 43 (37) 27 (25) 16 (12)
Interstitial inﬁltrate 43 (21) 27 (17) 16 (4)
Upper mid-dermal inﬁltrate 43 (33) 27 (23) 16 (10)
Lower mid-dermal inﬁltrate 30 (8) 18 (5) 12 (3)
Eosinophils 41 (32) 26 (21) 15 (11)
Neutrophils inﬁltrate 43 (32) 27 (22) 16 (10)
Neutrophils papillary 38 (14) 26 (13) 12 (1)
Leukocytoclasia 33 (11) 24 (7) 9 (4)
Psoriasiform (epidermal) changes
Hyperkeratosis 7 (0) 5 (0) 2 (0)
Parakeratosis 16 (3) 12 (3) 4 (0)
Stratum granulosum 9 (1) 8 (1) 1 (0)
Rete ridge changes 20 (11) 16 (11) 4 (0)
Mitosis 43 (6) 27 (4) 16 (2)
Suprapapillary plate thinning 0 (0) 0 (0) 0 (0)
Tortuous, dilated blood vessels 7 (1) 6 (1) 1 (0)
AGEP, acute generalized exanthematous pustulosis.
(A) (B)
Fig. 2. Histopathologyofchronicgeneralizedpustularpsoriasis(cGPP). A) Club-shapedpsoriaticreteridgeswithhyperkeratosis,parakeratosis,
Munro abscesses (arrows), epidermal plate thinning and sub-/intracorneal pustule with dilated, tortuous vessels (arrowhead) and superﬁcial
perivascular mononuclear inﬁltrates. B) Hyperkeratosis, parakeratosis and psoriatic rete ridge elongation with pustules at several levels
(arrows), neutrophilic exocytosis, mainly mononuclear perivascular inﬁltrate, and dilated papillary vessels. Hematoxylin and eosin, original
magniﬁcation: (A,B) ×100.
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Table 3. Comparison of histopathological features in pustular lesion in AGEP, aGPP and cGPP
Prevalence Signiﬁcance (p value)
AGEP pustule n = 27 aGPP n = 14 cGPP n = 10 AGEP AGEP
Histopathological parameters (grade 2,3) (grade 2,3) (grade 2,3) aGPP cGPP
Pustules
Munro(-like) abscesses 7 (4) 1 (1) 8 (8) NS <0.01
Intra-/subcorneal pustules 24 (18) 14 (14) 10 (10) <0.01 0.02
Spongiform 18 (12) 14 (13) 10 (5) <0.01 NS
Subcorneal-intraepidermal pustules 18 (18) 8 (8) 3 (3) NS 0.02
Spongiform 18 (15) 8 (8) 3 (3) NS NS
Eosinophils in pustule 16 (9) 0 (0) 0 (0) <0.01 <0.01
Macro-pustules 17 (12) 14 (13) 10 (4) <0.01 0.01
Hair follicular pustules 8 3 2 NS NS
Epidermis
Necrotic keratinocytes 22 (16) 2 (0) 1 (0) <0.01 <0.01
Neutrophilic exocytosis 26 (16) 13 (11) 10 (6) NS NS
Spongiosis 27 (12) 14 (5) 9 (0) NS <0.01
Dermis
Papillary edema 25 (12) 13 (4) 7 (1) NS NS
Superﬁcial inﬁltrate 27 (25) 14 (7) 10 (4) <0.01 <0.01
Interstitial inﬁltrate 27 (17) 9 (3) 3 (1) <0.01 <0.01
Upper mid-dermal inﬁltrate 27 (23) 5 (0) 7 (2) <0.01 <0.01
Lower mid-dermal inﬁltrate 18 (5) 3 (0) 0 (0) 0.01 <0.01
Eosinophils 26 (21) 1 (0) 2 (0) <0.01 <0.01
Neutrophils inﬁltrate 27 (22) 14 (6) 8 (4) 0.04 0.02
Neutrophils papillary 26 (13) 14 (13) 8 (5) <0.01 NS
Leukocytoclasia 24 (7) 7 (2) 2 (0) 0.03 <0.01
Psoriasiform (epidermal) changes
Hyperkeratosis 5 (0) 4 (2) 10 (8) NS <0.01
Parakeratosis 12 (3) 4 (2) 9 (6) NS <0.01
Stratum granulosum 8 (1) 10 (3) 10 (7) 0.03 <0.01
Rete ridge changes 16 (11) 6 (4) 10 (9) NS 0.02
Mitosis 27 (4) 14 (5) 10 (7) 0.05 <0.01
Suprapapillary plate thinning 0 (0) 1 (0) 5 (2) NS <0.01
Tortuous, dilated blood vessels 6 (1) 13 (12) 10 (10) <0.01 <0.01
AGEP, acute generalized exanthematous pustulosis; aGPP, acute generalized pustular psoriasis; cGPP, chronic generalized pustular psoriasis;
NS, non-signiﬁcant.
varied localization (Fig. 1A–D). Moreover, biopsies
from pustules showed more pronounced rete ridge
changes (Fig. 1C,D) and heavier inﬁltrates.
Comparison of 27 biopsies from pustules in
AGEP with 14 biopsies of aGPP and 10 of cGPP
showed several signiﬁcant differences (Table 3). In
GPP, pustules contained no eosinophils. Compared
to AGEP, they generally contained more lysed
keratinocytes and were more spongiform and were
situated at a slightly higher epidermal level. Macro-
pustules were prominent in GPP; in cGPP they
were often situated at a more superﬁcial epidermal
level (Fig. 2A), while in aGPP they were often
quitelarge(Fig. 3A).Psoriasiformepidermalchanges
were most prominent in cGPP (Fig. 2A,B). Most
striking in GPP was the consistent presence of
tortuous, dilated blood vessels (96%) (Figs. 2A,B and
3B). Compared with AGEP, necrotic keratinocytes
and dermal eosinophils were signiﬁcantly less
present in GPP. The inﬁltrate in GPP was mainly
superﬁcial,perivascular,lesspronounced andmainly
mononuclear, while in AGEP the inﬁltrate was
also deeper and interstitial. Neutrophils in aGPP
were markedly located in the papillary dermis in
comparison to AGEP and cGPP (Fig. 3A–C).
Histopathology of a subgroup of seven AGEP
patientswithapersonalhistoryofpsoriasisshowedno
signiﬁcant differences with cases without pre-existing
psoriasis. However, slight psoriasiform changes and
presence of tortuous/dilated blood vessels were seen
more often in this subgroup (Fig. 1D).
Discussion
We believe that the strength of our study is the




Fig. 3. Histopathology of acute generalized pustular psoriasis (aGPP). A) Subcorneal macro-pustule, neutrophilic exocytosis, superﬁcial
perivascular, mainly mononuclear, inﬁltrates with papillary neutrophils. B) Subcorneal/intraepidermal spongiform macro-pustule of Kogoj,
neutrophilic exocytosis, slightly psoriasiform rete ridge changes and dilated papillary vessels. C) Detail macro-pustule: neutrophilic exocytosis,
papillary neutrophils and superﬁcial perivascular, mainly mononuclear inﬁltrate. Hematoxylin and eosin, original magniﬁcation: (A) ×40,
(B) ×200 and (C) ×100.
set of histopathological parameters. Both AGEP
and GPP represent a dynamic spongiotic pustular
process. This presumably starts with dermal edema
and a perivascular inﬁltrate, and this is followed by
pustules in different stages of evolution. Because of
this evolution, we studied the features of AGEP in
erythema and visible pustules. While cGPP develops
over time, aGPP represents acute pustule formation
onpreviouslyuninvolvedskin.Differentialdiagnostic
problems between AGEP and GPP particularly arise
in the acute phase of GPP.
It is noteworthy that we found small pustules in
all biopsies from erythematous lesions of AGEP. In
aGPP, pustules were concentrated somewhat deeper
in the epidermis than in cGPP. In biopsies from
pustular lesions of AGEP, pustules of different sizes
were distributed over several levels, probably reﬂect-
ing the ongoing process with pustules at consecutive
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stagesinonebiopsy.Subcornealpustules,contiguous
to intraepidermal ones, were markedly spongiform
in AGEP but were generally less prominent than in
GPP.4,19,20,24 Differences in localization and spongi-
form character of pustules in a biopsy can provide a
hint for differentiating AGEP from GPP. Although
in AGEP, pustules were generally non-follicular, fol-
licular pustules could sometimes be observed as well.
In our experience, follicular pustules do not exclude
the diagnosis of AGEP.
Munro micro-abscesses, representing collections
of neutrophils within parakeratosis, are generally
associated with psoriasis. However, in AGEP we
also observed variously sized late-stage (dried)
intracorneal pustules that assumed the conﬁguration
of Munro micro-abscesses. The higher frequency of
Munro micro-abscesses and of other intracorneal
pustules in cGPP can be explained by its more
protracted course compared with AGEP or aGPP.
Spongiformmacro-pustulesweredominantlypresent
in GPP. Although generally associated with GPP
and not with AGEP, those macro-pustules were also
regularly (63%) observed in biopsies of AGEP when
taken from pustular lesions.
Whether histopathological features of conven-
tional plaque-type psoriasis can be seen in GPP
is controversial.18,25,26 Our study suggests that this
controversy is mainly a matter of timing, because
psoriatic changes such as hyperkeratosis, paraker-
atosis, a diminished stratum granulosum, rete ridge
changes, elevated mitotic index and suprapapillary
plate thinning were far more prominent in cGPP.
We believe this isbecause of its more chronic stage in
comparison with aGPP. In aGPP the epidermis was
often only slightly acanthotic, as in AGEP. Absent
or minor alterations of the stratum corneum, partic-
ularly in early lesions of AGEP but also in aGPP,
indicate an acute process. Rete ridge change (such
as elongation), generally mild, was more frequent in
AGEP than generally reported and in our view is
apparently less a key point in favor of GPP than
previously assumed.11,18,19 Alterations in rete ridge
point to a more developed stage of lesion, since
we found them more prominently in pustular than
erythematous AGEP lesions (59%), especially when
desquamating intracorneal pustules were present.
Although substantial psoriasiform changes in a pus-
tularlesionaresuggestiveofGPP,theirabsence(such
as in aGPP) does not necessarily exclude GPP. On
the other hand, minor psoriasiform changes do not
rule out AGEP.
While tortuous, dilated vessels were expected in
cGPP, we surprisingly also observed them signiﬁ-
cantly more in aGPP than in AGEP. Moreover, in
AGEP they were strongly associated with cases hav-
ing a personal history of psoriasis (data not shown).
Presumably vascular alterations are very speciﬁc for
psoriasis and are widely present in patients with the
disease.
Necrotic keratinocytes, also observed in other
drug eruptions, were generally few or scattered out-
side the pustule in AGEP (88%), while in GPP we
hardly found them.24 On the other hand, lysed ker-
atinocyteswithinthepustulesweremorepronounced
in GPP, resulting in slightly more spongiform pus-
tules, especially in aGPP.15,18,25 In AGEP, apopto-
sis of activated keratinocytes is mainly caused by
CD8+ lymphocytes, but CD4+ drug-speciﬁc cyto-
toxic T cells also play a role.27
Dermal edema is relatively characteristic (but not
speciﬁc) for AGEP, especially in its early stages.16,20
Althoughlessmarkedthanoftensuggested,moderate
to severe papillary edema was present in 40%
of biopsies from patients with AGEP, in 29% of
biopsies from patients with aGPP and almost absent
in biopsies from patients with cGPP.
Eosinophils in pustules, in the dermis and also
in the peripheral blood, a hallmark of many drug-
induced allergic reactions, suggests that AGEP is a
hypersensitivity reaction.18,28 Although the process
of eosinophilic exocytosis was observed in just four
biopsies (data not shown), sparse eosinophils were
found in 58% of the pustules.4,16 Dermal eosinophils
were more frequent (95%) although less pronounced
than sometimes reported.4,17,18,22–24 In contrast to
AGEP, eosinophils were only found sporadically in
GPP.26
Remarkably, an interstitial and perivascular mid-
dermal inﬁltrate is not generally considered a fea-
ture of AGEP. We found such an inﬁltrate to
be pronouncedandmixed,oftenincludingnumerous
neutrophils. In GPP, the inﬁltrate wasless dense, was
located more superﬁcially and was mainly mononu-
clear, while neutrophils were found predominantly
in the papillary dermis. We believe these differences
in composition and distribution can be diagnostically
meaningful.
We regularly noticed erythrocyte extravasation
(notgenerallyreported)andmildleukocytoclasia,but
alterations suggesting possible vasculitis, including
ﬁbrin deposition in the vessel wall, was seen only
once in AGEP. Absence of clear evidence for
vasculitisinthepresenceoferythrocyteextravasation
and leukocytoclasia has been mentioned before.20,21
Acute vasculitis in AGEP is sometimes reported in
a connection of subepidermal with intraepidermal
pustules, which is something we did not observe.17,24
Overreporting of vasculitis might be caused by
interpretation of leukocytoclasia and/or erythrocyte
extravasation as vasculitis or by diagnostic confusion
with pustular vasculitis. Purpura may occur in
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AGEP and other drug-induced eruptions, even in
the absence of vasculitis.
An earlier clinical study of 63 cases of AGEP,
including 64 biopsies from 48 patients, mentions
superﬁcial spongiform pustules (66%), focal necrotic
keratinocytes (25%), psoriasiform hyperplasia (39%),
mixed perivascular inﬁltrates with eosinophils
(34%), papillary edema (61%) and leukocytoclastic
vasculitis (20%) including ﬁbrinoid changes (11%).16
Remarkably, our study showed far more pustules,
papillary edema (91%), dermal eosinophilia (95%)
andnecrotickeratinocytes(88%).Thismightindicate
that biopsies in these two studies were taken
at different stages. We found far less ﬁbrinoid
alteration, while psoriatic changes were comparable.
Differencesmightalsobeattributedtocasedeﬁnition,
inclusion criteria and use of step sections in our
study.
AGEP can also occur in patients with plaque
psoriasis. It has been suggested that AGEP merely
represents a variant of GPP, and thus signiﬁes an
acute exacerbation of psoriasis caused by a variety of
exogenous triggers. However, analysis of a subgroup
of seven AGEP cases with a known personal history
of psoriasis in our study did not show signiﬁcant
differenceswiththeothercases.Also,theobservation
of several signiﬁcant differences in GPP vs. AGEP
supports the concept that AGEP is a separate entity
that can occur as an acute eruption in patients with
a history of psoriasis. On the basis of our ﬁndings,
therearenogroundstoassumethatanacutepustular
rash, occurring in patients with known psoriasis, is
necessarilyGPPorthatAGEPisavariantofpustular
psoriasis.
As noticed before, the prevalence of patients with
a personal history of psoriasis in our study of AGEP
(26.9%) was higher than could be expected from
thegeneralpopulation (1–4%).3,5,16,29,30 This higher
prevalence might indicate that patients with GPP
and AGEP share a common genetic background,
whichdirectsthemtoreactwithneutrophil-attracting
mechanisms.
The etiopathogenesis of AGEP is still not fully
elucidated although some progress has been made.
Positive results from patch and lymphocyte transfor-
mation tests with the suspected agent, indicating
a delayed type IV hypersensitivity reaction, sup-
port a drug etiology and the concept that T cells
play a crucial role.21,31 It was recently appreciated
that interleukin-8 (IL-8), secreted by T cells and ker-
atinocytes, enhances neutrophilic inﬂammation and
survival, thus leading to sterile pustular lesions.31,32
Similar mechanisms seem to be relevant for other
T-cell-mediateddiseaseswithneutrophilicinﬂamma-
tion, like GPP, which has an underlying tendency for
a Th1-dominated immune response.32–35 Besides,
few CXCL8+ T cellsdisplayingaTh2-type cytokine
proﬁle with high IL-4 and IL-5 secretions, may
contribute to the eosinophilia, regularly observed
in AGEP.32 In GPP, IL-5 is not secreted, which
might explain the absence of eosinophilia.28,36
Conclusions
In summary, the present study found a spectrum of
histopathological features of both AGEP and GPP.
Differentiating AGEP from GPP, especially aGPP,
presents a clinical and histopathological challenge.
Whereas no single histopathological feature is
decisive on its own, the combination of features and
their grade of severity can substantially contribute
to negotiating this differential diagnosis successfully.
Features pointing at AGEP instead of GPP include
the presence of eosinophils in the pustules or dermis,
necrotic keratinocytes, a mixed neutrophil-rich
interstitial and mid-dermal inﬁltrate and the absence
of tortuous, dilated blood vessels. Moreover, cGPP
showed signiﬁcant epidermal psoriasiform changes.
These key histopathological features, combined
with clinicopathological correlation, will assist in
differentiation between AGEP and GPP in most
instances.
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